EUVIMEDEUVIMED entdecken
Open Access

Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates

Pragya Kakani, Michael Anne Kyle, Amitabh Chandra, Luca Maini

Health Affairs · 2024

DOI: 10.1377/hlthaff.2024.00273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2024. Verfasst von Pragya Kakani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pragya Kakani (pka4006@med.cornell.edu), Cornell University, New York, New York. Hauptthemen laut MEDLINE: Medicare Part D. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans' ability to negotiate rebates and lead to higher spending. We estimated the association between protected-class status, US-level estimated rebates, and formulary coverage during the period 2011-19. We found that protected classes indeed had significantly lower exclusion rates in Medicare Part D during this period relative to nonprotected classes, and this difference was larger than the corresponding difference in commercial plans. US-level average rebates grew 22.5 percentage points less in protected than in nonprotected classes during 2011-19, a period when formulary exclusions increased. Relative to nonprotected classes, US-level average rebates in protected classes were especially low among drugs with high Medicare market share. These results suggest that Medicare Part D protected-class policy may reduce rebates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medicare Part DUnited StatesHumansFormularies as TopicDrug CostsInsurance CoverageHealth PolicyPrescription Drugs

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • Pragya Kakani (pka4006@med.cornell.edu), Cornell University, New York, New York.
  • Michael Anne Kyle, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Amitabh Chandra, Harvard University, Boston, Massachusetts.
  • Luca Maini, Harvard University.

Förderung

  • NCI NIH HHS
  • NIA NIH HHS

Zitieren

APA

Kakani, P., Kyle, M. A., Chandra, A., & Maini, L. (2024). Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates. Health Affairs. https://doi.org/10.1377/hlthaff.2024.00273

Vancouver

Kakani P, Kyle MA, Chandra A, Maini L. Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates. Health Affairs. 2024. doi:10.1377/hlthaff.2024.00273

BibTeX
@article{Kakani2024,
  author = {Kakani, Pragya and Kyle, Michael Anne and Chandra, Amitabh and Maini, Luca},
  title = {Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates},
  journal = {Health Affairs},
  year = {2024},
  doi = {10.1377/hlthaff.2024.00273}
}
Kostenlos starten →